Bone Turnover and Lipid Metabolism in Response to Vagal Nerve Stimulation

Bone Turnover and Lipid Metabolism in Response to Vagal Nerve Stimulation - Bone turnover, lipid metabolism and the vagal nerve

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37555

Enrollment

Registered

2012-04-23

Start date

2012-06-15

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

botmetabolisme bone turnover lipid metabolism

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients eligible for vagal nerve stimulator implantation Age >18 years

Exclusion criteria

Exclusion criteria: Incapability of giving informed consent

Design outcomes

Primary

Measure	Time frame
Bone turnover: The main outcome parameter is the change of serum concentrations of bone turnover markers (procollagen type I N propeptide (P1NP) and C-terminal crosslinking telopeptides of collagen type I (CTX)). Lipid metabolism: The main outcome parameter is the change of the plasma lipid profile (cholesterol, LDL, HDL, triglycerides).	—

Countries

Netherlands

Outcome results